• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
CMB 0.00% 41.0¢

CAMBIUM BIO LIMITED

Cambium Bio Limited, formerly Regeneus Ltd, is an Australia-based clinical-stage... Cambium Bio Limited, formerly Regeneus Ltd, is an Australia-based clinical-stage regenerative medicine company focusing on the development of biologics for ophthalmology and tissue repair applications. Its technology, based on human platelet lysate, is being leveraged to create a pipeline of novel therapeutics, with a primary focus on ophthalmology. Its lead product candidate, Elate Ocular, is being developed to address significant unmet medical needs in the treatment of dry eye disease. Elate Ocular is formulated from the processing of base human platelets sourced not from patients, but generally healthier younger eligible donors at U.S. blood collection centers. In addition, its stem cell platform, Progenza, is being applied to the development of therapies for knee osteoarthritis and other tissue repair indications. It also manufactures and sells stem cell growth supplements, such as UltraGRO Advanced, UltraGRO Pure (xeno-free), and UltraGRO Pure GI (xeno-free, gamma irradiated).More

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
CMB 30/10/24 0 151
30/10/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  151 
CMB 25/10/24 0 90
25/10/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  90 
CMB 15/10/24 0 273
TRENDING NEWS

UAV Magnetic Survey Starts at Portland Creek Covering New Geochemical Anomalies

I88
08 Nov 2024
INFINI RESOURCES LIMITED
15/10/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  273 
CMB 10/10/24 0 105
10/10/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  105 
CMB 10/10/24 0 266
10/10/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  266 
CMB 02/10/24 0 174
02/10/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  174 
CMB 04/09/24 1 840
04/09/24 Last post  Biotechasx Comments Created with Sketch.  1  Views Created with Sketch.  840 
CMB 30/08/24 0 106
30/08/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  106 

See All Discussions arrow Created with Sketch.

Timeline

Quarterly Activities/Appendix 4C Cash Flow Report
30 Oct 17:46
 
Notice of Annual General Meeting/Proxy Form
25 Oct 09:51
 
CEO Acquires Shares Demonstrating Strong Confidence
15 Oct 12:53
 
Initial Director's Interest Notice - Chang
10 Oct 12:58
 
Cambium Bio Strengthens Leadership with Two Key Appointments
10 Oct 11:02
 
Date of AGM
02 Oct 17:27
 
View More arrow Created with Sketch.
(20min delay)
Last
41.0¢
Change
0.000(0.00%)
Mkt cap ! $4.891M
Open High Low Value Volume
41.0¢ 41.0¢ 41.0¢ $121 294

Buyers (Bids)

No. Vol. Price($)
2 3870 41.0¢
 

Sellers (Offers)

Price($) Vol. No.
48.0¢ 24 1
View Market Depth
Last trade - 10.02am 08/11/2024 (20 minute delay) ?
CMB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.